Focused on delivering a more affordable, novel proton-based radiotherapy system, based on a technology originally developed and tested at the world renowned CERN facility in Switzerland. Its uniqueness lies in the fact that the accelerator is a linear one which confers substantial benefits and flexibility to the operator, payor and patient. With its first purchase order in March 2015 ($40m) as well as the recent agreement with CircleHealth, to have the first installation of a LIGHT system in 2016-2017 in London, the Company is entering a c.$680m market on the cusp of a steepening adoption curve with a disruptive technology.
19 Oct 2015
Disruptive technology in high growth market
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Disruptive technology in high growth market
Advanced Oncotherapy Plc (AVO:LON) | 1.9 0 0.0% | Mkt Cap: 10.4m
- Published:
19 Oct 2015 -
Author:
Mark Brewer -
Pages:
44
Focused on delivering a more affordable, novel proton-based radiotherapy system, based on a technology originally developed and tested at the world renowned CERN facility in Switzerland. Its uniqueness lies in the fact that the accelerator is a linear one which confers substantial benefits and flexibility to the operator, payor and patient. With its first purchase order in March 2015 ($40m) as well as the recent agreement with CircleHealth, to have the first installation of a LIGHT system in 2016-2017 in London, the Company is entering a c.$680m market on the cusp of a steepening adoption curve with a disruptive technology.